Geovax Labs (GOVX) closed at $0.17 on October 30, 2026, down 9.4% from the previous close, on volume of 222,499 shares (30-day average 639,862).
Data as of October 30, 2026.
No press releases found.
GeoVax Stockholders Approve Warrants and Reverse Split
TipRanks (Tue, 27-Oct 1:27 PM ET)
GeoVax Secures New Loan Facility and Reshapes Board
TipRanks (Tue, 27-Oct 9:30 AM ET)
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
Geovax Labs trades on the NASDAQ stock market under the symbol GOVX.
As of October 30, 2026, GOVX stock price declined to $0.17 with 222,499 million shares trading.
GOVX has a beta of 2.85, meaning it tends to be more sensitive to market movements. GOVX has a correlation of 0.04 to the broad based SPY ETF.
GOVX has a market cap of $878,484.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, GOVX traded as high as $279.50 and as low as $.17.
The top ETF exchange traded funds that GOVX belongs to (by Net Assets): VXF.
GOVX has underperformed the market in the last year with a price return of -98.8% while the SPY ETF gained +11.0%. GOVX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -75.9% and -34.6%, respectively, while the SPY returned +3.9% and -2.1%, respectively.
GOVX support price is $.17 and resistance is $.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GOVX shares will trade within this expected range on the day.
